Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
SEATTLE, Wash. --(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified
View HTML
Toggle Summary NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
SEATTLE --(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other factors, $175 million aggregate principal amount of convertible senior notes
View HTML
Toggle Summary NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
SEATTLE --(BUSINESS WIRE)--Feb. 26, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31, 2019 . Fourth Quarter Financial Highlights Product and
View HTML
Toggle Summary NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
Presenting Ten Research Studies using the Cancer Transcriptome Atlas to Discover Novel Biomarkers and First Data from Forthcoming Whole Transcriptome Atlas Unveiling GeoMx DSP Roadmap at 2 nd Annual Spatial Genomics Summit on Sun February 23 rd SEATTLE --(BUSINESS WIRE)--Feb.
View HTML
Toggle Summary NanoString to Present at the 40th Annual Cowen Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Feb. 18, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 40 th Annual Cowen Healthcare Conference in Boston .
View HTML
Toggle Summary NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
SEATTLE --(BUSINESS WIRE)--Feb. 10, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on
View HTML
Toggle Summary Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
Deep Molecular Profiling of Immune Cells Critical for Survival and Response to Therapy in Patients with Metastatic Melanoma SEATTLE --(BUSINESS WIRE)--Jan. 15, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced
View HTML
Toggle Summary NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019
— FY19 Product and Service Revenue of $103.7 million , including GeoMx DSP Revenue of $10.8 million , Exceeds High End of Guidance Ranges — — Over 90 Cumulative GeoMx DSP Orders as of Year End — SEATTLE --(BUSINESS WIRE)--Jan. 12, 2020-- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Jan. 2, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 38 th Annual JP Morgan Healthcare Conference in San Francisco .
View HTML
Toggle Summary NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
Consortium Plans to Apply Spatial Analysis to Major Challenges in Breast Cancer Research SEATTLE --(BUSINESS WIRE)--Dec. 11, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast
View HTML